Agios Pharmaceuticals
Developing therapies for rare and genetically defined diseases.
Company facts
- Founded
- 2008
- Employees
- 540
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: AGIO
About
Agios Pharmaceuticals is a commercial‑stage biopharmaceutical company specializing in the development of innovative medicines for rare diseases, with a particular focus on hematology and cellular metabolism. Leveraging deep scientific expertise and real‑world insights, Agios advances a growing pipeline of therapies designed to address the unmet needs of rare disease communities, delivering treatments that have the potential to transform patients’ lives. The company’s collaborative culture and strong partnerships with patients, advocacy groups, and research institutions underpin its commitment to bold, science‑driven solutions that create lasting value for both patients and employees.